Exploring the Use of a Cell Surface Marker as a Target for Precision Therapy of Hemangiosarcoma
SUMMARY: Researchers will build on earlier research to assess whether the cell surface marker integrin α6β4 can be used as a treatment target.
Researchers will investigate targeted therapies for the treatment of B-cell lymphoma in dogs.
Morris Animal Foundation's Golden Retriever Lifetime Study will help identify major nutritional, genetic and environmental risk factors for cancer and other important diseases in dogs.